RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer
Cancer Letters · 2026
DOI: 10.1016/j.canlet.2026.218560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Gengdu Qin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Sino-G…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Oxidative Phosphorylation, Proto-Oncogene Proteins c-myc, Ubiquitin-Protein Ligases. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wuhan Union Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
RNF43 is frequently inactivated by mutations in pancreatic ductal adenocarcinoma (PDAC), but the molecular mechanisms and therapeutic vulnerabilities associated with RNF43 loss remain poorly defined. Here, we demonstrate that RNF43 functions as an E3 ubiquitin ligase targeting YBX1 for degradation, thereby suppressing mitochondrial oxidative phosphorylation (OXPHOS). In RNF43-deficient PDAC models, stabilized YBX1 activates MYC through dual mechanisms-enhancing MYC mRNA stability via IGF2BP1 and physically interacting with c-Myc protein-leading to transcriptional upregulation of IDH2 and IDH3A and subsequent OXPHOS activation. Importantly, RNF43 loss conferred sensitivity to OXPHOS inhibition both in vitro and in vivo. Treatment with the OXPHOS inhibitor IACS-010759 suppressed the proliferation, migration, invasion, and metastasis of RNF43-mutant tumors. Our findings identify a RNF43-YBX1-MYC signaling axis associated with metabolic reprogramming in pancreatic cancer and suggest that OXPHOS inhibition may represent a potential therapeutic vulnerability in tumors with RNF43-inactivating mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Sino-German Laboratory of Personalized Medicine for Pancreatic Cancer, Union…
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Förderung
- Wuhan Union Hospital
- National Natural Science Foundation of China
Zitieren
APA
Qin, G., Pan, P., Qin, Y., Wei, R., Zhao, Y., Fu, Q., Yu, H., Liu, J., Wu, H., Liu, Z., & Zhou, Y. (2026). RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218560
Vancouver
Qin G, Pan P, Qin Y, Wei R, Zhao Y, Fu Q, et al. RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218560
BibTeX
@article{Qin2026,
author = {Qin, Gengdu and Pan, Penglin and Qin, Yang and Wei, Ruozheng and Zhao, Yuhan and Fu, Qixun and Yu, Haixin and Liu, Jiaying and Wu, Heshui and Liu, Zhiqiang and Zhou, Yingke},
title = {RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer},
journal = {Cancer Letters},
year = {2026},
doi = {10.1016/j.canlet.2026.218560}
}
EUVIMED